Biochimica et Biophysica Acta (BBA)/Gene Structure and Expression

Preface
pp. 1-1(1)
Author: Nielsen P.E.

Novel mechanisms for antisense-mediated regulation of gene expression
pp. 3-18(16)
Authors: Baker B.F.; Monia B.P.

Antisense oligonucleotides as a tool for gene functionalization and target validation
pp. 19-30(12)
Authors: Bennett C.F.; Cowsert L.M.

Molecular mechanisms of action of antisense drugs
pp. 31-43(13)
Author: Crooke S.T.

Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments
pp. 45-52(8)
Author: Stein C.A.

Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides
pp. 53-67(15)
Author: Agrawal S.

A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides
pp. 69-84(16)
Author: Levin A.A.

Oligonucleotide therapeutics for hematologic disorders
pp. 85-96(12)
Authors: Agarwal N.; Gewirtz A.M.

Human Bcl-2 antisense therapy for lymphomas
pp. 97-106(10)
Authors: Cotter F.E.; Waters J.; Cunningham D.

Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
pp. 107-116(10)
Author: Krieg A.M.

2'-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation
pp. 117-130(14)
Author: Manoharan M.

Oligonucleotide N3'->P5' phosphoramidates as potential therapeutic agents
pp. 131-140(10)
Author: Gryaznov S.M.

Morpholino antisense oligomers: the case for an RNase H-independent structural type
pp. 141-158(18)
Author: Summerton J.

Antisense properties of peptide nucleic acid
pp. 159-166(8)
Authors: Larsen H.J.; Bentin T.; Nielsen P.E.

Conformationally restricted carbohydrate-modified nucleic acids and antisense technology
pp. 167-179(13)
Author: Herdewijn P.

Triple helix formation and the antigene strategy for sequence-specific control of gene expression
pp. 181-206(26)
Authors: Praseuth D.; Guieysse A.L.; Helene C.